{"id":8716,"date":"2017-11-25T05:00:01","date_gmt":"2017-11-25T10:00:01","guid":{"rendered":"https:\/\/medicarereport.org\/?p=8716"},"modified":"2017-11-22T13:56:09","modified_gmt":"2017-11-22T18:56:09","slug":"a-scrappy-upstart-in-the-pain-pill-business-takes-on-mighty-purdue-pharma","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=8716","title":{"rendered":"A scrappy upstart in the pain pill business takes on mighty Purdue Pharma"},"content":{"rendered":"<p>(By Rebecca Robbins for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">CANTON, Mass. \u2014 Collegium Pharmaceutical, the scrappy upstart taking on the mighty opioid maker Purdue Pharma, is having a moment. <a href=\"https:\/\/www.statnews.com\/2017\/11\/22\/opioids-collegium-purdue-pharma\/\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rebecca Robbins for STAT) CANTON, Mass. \u2014 Collegium Pharmaceutical, the scrappy upstart taking on the mighty opioid maker Purdue<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,15],"tags":[],"class_list":["post-8716","post","type-post","status-publish","format-standard","hentry","category-medical-technology","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8716"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8716\/revisions"}],"predecessor-version":[{"id":8717,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8716\/revisions\/8717"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}